Pharmaceutical Supply Chain

Cencora Commits Over $1 Billion to U.S. Drug Distribution Buildout Through 2030

The expansion targets soaring cold‑chain demand for specialty medicines, aligning with U.S. efforts to bolster domestic drug supply resilience.